300 likes | 444 Views
Quality Wins. NTUH. Defining Optimal Care of CKD : ( CV Risk management … … ). 洪冠予醫師 2009/10/18. Q1 . What’s the Mission of this talk ? … …. 孟子 見 梁惠王 : 王 : 『 叟,不遠千里而來,亦將有以利吾國乎 ?』 孟子 : 『 王何必曰利,亦有仁義而已矣。 』. (n=2,434, CAD 18.9%).
E N D
Quality Wins NTUH Defining Optimal Care of CKD: (CV Risk management……) 洪冠予醫師 2009/10/18
Q1.What’s the Mission of this talk ?… … 孟子見梁惠王: 王: 『叟,不遠千里而來,亦將有以利吾國乎?』 孟子: 『王何必曰利,亦有仁義而已矣。』
DM, HT, and Hyperlipidemia associated with increased CKD risk Kuo HW et al. AJKD, 49:46-55, 2007 AVD : Athrosclerotic vascular disease Adjusted for age, sex, region, coronary artery disease, cerebrovascular accident, transient ischemic attack, and peripheral vascular disease
All-cause mortality attributable to CKD:a prospective cohort study (462,293 adults) in Taiwan (Lancet. 2008 Jun 28;371(9631):2173-82)
Mortality Risks for All Causes and CV Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan(AJKD 2008 Aug 14. [Epub ahead of print])
標竿學習…… 腎臟病防治的重點是什麼 ? Q2.貴院的CKD 衛教計畫,重點項目為: # Who ? # What ? # When ? # How ?
Kidney protection: a key target in the management of patients with diabetes (J Hypertens 2009 May;27(suppl 1):S15–S18) Microalbuminuria LVH arteriopathy Overt CVD, Advanced CKD, or both.
【 RAADual Blockade for Cardiorenal Protection: An Update 】 Am J Kidney Dis 2009 Feb; 332-345
Renin Concentration (PRC) vsRenin Activity (PRA) Am J Med (2008 Apr);121: 265-71
By what standard ? 標竿學習…… Q3.貴院CKD病人CVD現況與醫療計畫為何? # 1 # 2
Kidney protection: a key target in the management of patients with diabetes (J Hypertens 2009 May;27(suppl 1):S15–S18)
糖尿病腎病變的整合照顧 (NEJM 2002,April 11)
[NEJM 2009; 360:1455-7] [AJKD 2009; 53(5):723-5] Q4. Is Statinbeneficial for CKD?
Staging of CKD BMJ 2006; 333: 733-7
Mortality Risks for All Causes and CV Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan(AJKD 2008 Aug 14. [Epub ahead of print])
(Am J Cardiol 2008;102:1668 –73) (GFR <60 /min) (GFR <50 /min)
Kidney Dysfunction as a CV Risk Factor Arch Intern Med 2008;168(6):617-624
Q6. From CKD to CVD: same mechanism? Traditional Risk Factors CV risk Oxidative Stress Inflammation Insulin resistance (metabolic syndrome)
Insulin Resistance, Adiponectin and Chronic Inflammation in Dialysis (HD & PD) Patients (Huang JW, Hung KY, et al. AJKD 2004;43:1047-55)
Implications of the Jupiter Trial ? [NEJM 2008; 359:2195-2207]
(Hung KY, et al. Eur J Endocrin 2009;160:1-9) Fetuin-A, insulin resistance in non-diabetic HD Patients Chronic inflammation, Insulin resistance in DM HD Patients (Hung KY, et al. Diabetes Care 2007;30:3-7)
Q7.Will you prescribe Cardio-protective agents for your CKD patients ? • Yes, always • Often • Seldom • No, never
Q8.Risk management: “Frequency and items of measurement” ?
Q9.FromCKD toCVD: mechanism ? Oxidative Stress Inflammation Insulin Resistance Traditional Risk Factors CV risk JASN 2008;19:1065–70